Workshop: Network Meta-Analyses for HTA

This workshop is being offered by the York Health Economics Consorium (YHEC), 20-21 February 2018

Indirect treatment comparisons (ITC) and mixed treatment comparisons (MTC), collectively referred to as Network Meta-Analysis (NMA), are increasingly used in health technology assessment. They are statistical techniques to synthesise available direct and indirect evidence to provide information on the comparative effectiveness and safety of a range of competing interventions.

Network meta-analyses are often complex and challenging projects to specify and undertake and bring with them a range of planning considerations that are critical for a successful end product. These considerations include specifying the review question, identifying relevant studies, deciding how to assess the similarity of studies in a potential network and developing the statistical analysis plan and using the NMA output in economic models.

This two day workshop is offered by experienced reviewers from YHEC and statisticians from Quantics who have collaborated together on many network meta-analyses to inform HTA submissions and market access planning exercises. The workshop is intended to offer project managers, research commissioners and others new to these techniques an introduction to the practical issues involved in commissioning and performing NMAs. This training day does not involve coding with WinBUGS or other programming software.

For further details please click link http://www.yhec.co.uk/training/practical-issues-in-producing-network-meta-analyses-for-htas-20th-and-21st-february-2018/  or contact Julie Glanville at julie.glanville@york.ac.uk

The Institute for Clinical Effectiveness and Health Policy, Argentina, is celebrating their 15th anniversary.

On behalf of all INAHTA members … Congratulations, IECS!

View IECS profile

Visit IECS website

HTAi now calls for abstract submissions for oral, vignette and poster presentations for the 2018 HTAi Annual Meeting in beautiful Vancouver, Canada, 1-5 June 2018.

Submission deadline: November 24, 2017

Visit the conference website for details.

Congratulations to OSTEBA for achieving 25 years of excellence in the evaluation of health technologies and supporting decisions in health care.

All are invited to attend a scientific conference on 24-25 October 2017.

Health Technologies life cycle. From investment to disinvestment
Cruces University Hospital, Plaza de Cruces, no number. Barakaldo–Bizkaia. Basque Country.

Visit conference website

To register

HTAi has opened the call for abstract submissions for the 2018 HTAi Annual Meeting in beautiful Vancouver, Canada, 1-5 June 2018.

Submission deadlines:

  •     Workshop & Panel Sessions: October 16, 2017
  •     Oral, Vignettes & Poster Presentations: November 24, 2017

Visit the conference website for details.

Congratulations to Saskia Knies, PhD, Senior Advisor at Zorginstituut Nederland (ZIN) for winning the David Hailey Award for Best Impact Story at the INAHTA Congress 2017.  Saskia's story was titled "A coverage decision on Eculizumab for aHUS: A success story?".

INAHTA members can access slides of her story in the members area (login required).

 

Tara Schuller, MSc, Executive Manager of the INAHTA Secretariat wins Best Oral Presentation at HTAi 2017 for her presentation of a collection of INAHTA member impact stories that will be published an upcoming mini-theme in IJTAHC.

Download slides "HTA impact: Stories from the front lines of hta production and use"

Tara is co-Associate Editor with Dr. Sophie Söderholm Werkö for the mini-theme, which will be published in IJTAHC later this year.  Tara's presentation gave some highlights of the six impact stories and some thematic analysis.

Congratulations to Tara and to the INAHTA members who contributed stories to the publication:
Manuscript Authors:
Alemán & Pérez:  Impact of HTA in litigation concerning access to high-cost drugs
Fujita-Rowherder, Sauerland & Rüther: Arthroscopic surgery for knee osteoarthritis: Impact of HTA in Germany
Ryan et al.: Contribution of stakeholder engagement to the impact of a HTA
Silhvo, Ikonen & Mäkelä: Implementing HTA-based recommendations in Finland: Managed uptake of medical methods.
Tivey et al.: Legislative and accreditation requirements for office-based surgery in Australia.
Truchon et al.: Shaping Quality in Quebec Trauma Through Vision and Quality Monitoring

Members are invited to review the program for the 2017 INAHTA Congress to be held 21-22 June at the Ergife Palace Hotel in Rome, Italy.
View here (login required)

This year, the conference theme is Building Bridges for Stronger HTA Agencies

On behalf of the INAHTA membership, the Board thanks the Rome Task Group for their work to develop the Congress program.

The Rome Task Group members:

Sophie Werkö (co-Chair), SBU, Sweden
Tara Schuller (co-Chair), Secretariat (IHE)
Marco Marchetti, UVT, Italy
Marina Cerbo, Agenas, Italy   
Luciana Ballini, ASSR, Italy   
Tracy Merlin, AHTA, Australia
Grace Huang, CDE, Taiwan

York Health Economic Consortium announces the following courses offered in 2017.  All courses are held at the University of York, but courses can also be delivered locally.

For further information on these courses please visit our training pages at: http://www.yhec.co.uk/training

The European Commission has released the results of a public consultation aimed to gather detailed views and opinions relating to the future of the EU cooperation on HTA, as proposed in the Inception Impact Assessment published by the European Commission. The results of this public consultation will feed into the impact assessment process which the Commission services are currently preparing on strengthening EU cooperation on HTA.

The EC received 250 replies to its public consultation on strengthening EU cooperation on Health Technology Assessment (HTA), 25% of which were from citizens and 75% from stakeholders. Almost all respondents (98%) acknowledge the usefulness of HTA, 81% consider the current EU cooperation on HTA to be useful to some degree, and 87% consider that EU cooperation on HTA should continue beyond 2020. Of those who support sustainable EU cooperation on HTA, 80% think the scope should include pharmaceuticals and 72% consider that medical technologies should also be covered.

The results of the public consultation and views expressed by stakeholders in other forums will be summarised in the Synopsis Report which will form part of the Impact Assessment on strengthening EU cooperation on HTA beyond 2020.

Read European Commission news release

Read full report